The clinical application of cytokine inhibitors, including those that antagonize the effects of TNF-α or IL-6, is often done with caution due to the complex nature of their signaling pathways, where alterations to one aspect may result in a myriad of unforeseen downstream effects such as infection or developing cancer (41, 42). Here, TNF is linked to infection.